Trevena
| Region | Nordamerika |
| ISIN | US89532E1091 |
| Sektor | Biotechnologie |
| Website | http://www.trevena.com/ |
At Trevena, our mission is to deliver innovative solutions to patients and healthcare providers confronting serious medical conditions. Our history is rooted in strong science – Trevena was founded to translate Nobel Prize-winning research into a new generation of groundbreaking medicines. Our novel approach to drug discovery has established us as pioneers in acute care medicine.
| Titel | Datum |
|---|---|
| Trevena's TRV027 Included In Global COVID-19 Study | vor 2 Stunden |
| Trevena shares rise 10% on selection of TRV027 in global COVID-19 trial | vor 3 Stunden |
| TREVENA INC - 8-K, Current Report | vor 3 Stunden |
| Trevena Inc.: Trevena Announces TRV027 Selected for Study in Global REMAP-CAP Trial in COVID-19 Patients | vor 3 Stunden |
| WKHS, EDIT, CLOV and TRVN among midday movers | vor 5 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| TrackX Holdings (1 Artikel) | |
| The Priceline Group (2 Artikel) | |
| United Internet (1 Artikel) | |
| Vapiano (2 Artikel) | |
| Alle anzeigen | |